QSS
RIGL icon

Quantitative Systematic Strategies’s Rigel Pharmaceuticals RIGL Stock Holding History

Quantitative Systematic Strategies’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,442
Closed -$46K – 632
2019
Q3 		$46K Sell
2,442
-727
-23% -$15K 0.01% 446
2019
Q2 		$83K Buy
3,169
+1,436
+83% +$32.4K 0.02% 447
2019
Q1 		$45K Buy
+1,733
New +$39.6K 0.01% 370

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quantitative Systematic Strategies's RIGL Position: Q4 2019 in Review

Quantitative Systematic Strategies sold out of Rigel Pharmaceuticals (RIGL) in Q4 2019, closing a stake of 2,442 shares — an estimated $46K sold.

Quantitative Systematic Strategies first reported a position in RIGL in Q1 2019 and held it in 3 quarters. The position peaked at $83K in Q2 2019. 136 funds tracked by Wall St. Rank hold RIGL as of Q4 2019.

  • Quantitative Systematic Strategies reported no remaining Rigel Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 2,442 Rigel Pharmaceuticals shares in Q4 2019, an estimated $46K.
  • Quantitative Systematic Strategies first reported a position in Rigel Pharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Rigel Pharmaceuticals position peaked at $83K in Q2 2019.
  • 136 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2019, filed 11 Feb 2020.